Certara Inc

$11.36
(as of May 30, 9:30 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Certara Inc

Stock Price
$11.36
Ticker Symbol
CERT
Exchange
NASDAQ

Industry Information for Certara Inc

Sector
Healthcare
Industry
Health Information Services

Company Description for Certara Inc

Country
USA
Full Time Employees
1,487

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara I

Fundamentals for Certara Inc

Market Capitalization
$1,849,467,520
EBITDA
$98,093,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
24.94
Earnings per Share
$-0.02
Earnings per Share Estimate Next Year
Profit Margin
-0.67%
Shares Outstanding
162,234,000
Percent Owned by Insiders
2.47%
Percent Owned by Institutions
100.87%
52-Week High
52-Week Low

Technical Indicators for Certara Inc

50-Day Moving Average
200-Day Moving Average
RSI
41.96
0.55

Analyst Ratings for Certara Inc

Strong Buy
4
Buy
1
Hold
6
Sell
0
Strong Sell
0

News About Certara Inc

May 7, 2025, 7:12 AM EST
Key Insights See more.
May 7, 2025, 7:09 AM EST
Certara (NASDAQ:CERT) First Quarter 2025 Results See more.
May 6, 2025, 8:31 AM EST
Participants See more.
May 6, 2025, 3:09 AM EST
Revenue: $106 million, 10% year-over-year growth. See more.